Peer-reviewed veterinary case report
CYTOKINE-RELEASE ASSAY FOR THE DETECTION OFINFECTION IN CHEETAH ().
- Journal:
- Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians
- Year:
- 2021
- Authors:
- Gumbo, Rachiel et al.
- Affiliation:
- Faculty of Medicine and Health Sciences
- Species:
- cat
Abstract
The lack of species-specific assays for the diagnosis of infectious diseases, such as bovine tuberculosis, poses a threat to the management of wildlife populations, especially for vulnerable species such as cheetah (). The aim of this study was to identify and develop a cell-mediated immunological cytokine-release assay that could distinguish between-infected and uninfected cheetahs using commercially available feline cytokine ELISA and domestic cat () recombinant proteins. Antibodies against domestic cat cytokines, tumour necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and interferon gamma (IFN-γ), were screened for cross-reactivity with plasma cytokines from cheetah whole blood stimulated using QuantiFERON-TB Gold Plus (QFT) tubes. Evidence of cytokine production in response to QFT mitogen stimulation was observed in all four ELISA assays. However only the Mabtech Cat IFN-γ ELISAkit could distinguish between-infected (= 1) and uninfected (= 1) cheetahs and was therefore selected for further evaluation. A preliminary cheetah specific cutoff value (11 pg/ml) for detectinginfection using the Mabtech Cat IFN-γ release assay was calculated using auninfected cheetah cohort. Although this study only included one confirmedculture-positive and oneculture-negative cheetah, the Mabtech Cat IFN-γ release assay demonstrated its potential for diagnostic application in this species.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/34998280/